Published in

University of Toronto Press, Canadian Liver Journal, 4(3), p. 309-321, 2020

DOI: 10.3138/canlivj-2020-0013

Links

Tools

Export citation

Search in Google Scholar

An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic

Journal article published in 2020 by Mayur Brahmania, Stephen Congly ORCID, Saumya Jayakumar, Carla S. Coffin, Kelly W. Burak, Jordan J. Feld
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Coronavirus disease 2019 (COVID-19) has challenged how care is delivered to patients with chronic liver disease (CLD). In an attempt to update Canadian health care practitioners taking care of individuals with CLD, the Canadian Association for the Study of the Liver (CASL) hosted a webinar on May 7, 2020, with more than 120 participants. The resultant article is a partnership between members of CASL’s executive and education committees to provide best practice management principles on liver disease during COVID-19 to the broader hepatology community.